Jounce Therapeutics, Inc.

CITADEL ADVISORS LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

77,599

Value ($000)

144

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	144	0.0%	77,599	3/31/2023
2022 Q4	2/14/2023	10	0.0%	8,944	12/31/2022
2022 Q3	11/14/2022	3,407	0.0%	1,455,862	9/30/2022
2022 Q2	8/15/2022	5,136	0.0%	1,694,867	6/30/2022
2022 Q1	5/16/2022	11,554	0.0%	1,701,554	3/31/2022
2021 Q4	2/14/2022	14,438	0.0%	1,729,036	12/31/2021
2021 Q3	11/15/2021	12,811	0.0%	1,724,251	9/30/2021
2021 Q2	8/16/2021	13,332	0.0%	1,960,601	6/30/2021
2021 Q1	5/21/2021	20,135	0.0%	1,960,547	3/31/2021
2020 Q4	2/16/2021	12,119	0.0%	1,731,349	12/31/2020
2020 Q3	11/16/2020	303	0.0%	37,125	9/30/2020
2020 Q2	8/14/2020	3,132	0.0%	453,902	6/30/2020
2020 Q1	5/15/2020	198	0.0%	41,846	3/31/2020
2019 Q4	2/14/2020	101	0.0%	11,616	12/31/2019